This part of the conference call is discussing the evaluation of Leronlimab in corona virus patients, the deal between CYDY and the Chinese company. Now, if leronlimab proves to be effective in corona virus patients, that could speed up the process, but just like the deal with Vyera, terms can take a long time to hammer out.